Answers
#1 in Business Subscribe Email Print

You are here: Home > Finance > Stocks Mutual Funds > Are You Trader Or An Investor?

Tags

  • possible
  • profit
  • should
  • developing combination

  • Links

  • Increase Productivity and Business Success - Take Responsibility
  • Technical Analysis an Art or Science?
  • Seniors Want To Stay At Home
  • Answers - Are You Trader Or An Investor?

    Firstly what is the difference between a trader and an investor?

    An investor is us
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    ually in for the medium to long term and is looking at a percentage (%) return on h
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    is capital outlay. Be it either shares or property investment. His main concern wou
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    d be the dividend return that the company pays.

    I f the current price of this asse
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    t declines but the income being generated has remained constant or much the same. T
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    en the investor sees no cause to sell.

    Now the trader buys an asset at the best pr
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    ice possible. This is with the intent to sell it again at a much higher price. Thes
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    e rewards often come from capital gains.

    Another factor is time as the investor is
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    in for the long haul whilst the trader is in for the shortest time possible to real
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    ise a satisfactory profit.

    Another difference is their respective understanding of
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    “risk not time.”

    The biggest difference is how they handle any downturns in the ma
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    rket. The trader seeing a downturn will exit the trade either taking a smaller prof
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    it or a small loss.

    The smart investor should do the same, but these are in the mi
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    ority. What usually happens is the investor believes that his stock selection crite
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    ria was correct and hopes that the market will reverse, so therefore he hangs on.

    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    nce it becomes apparent that the uptrend is finished it is usually too late to sell
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    because he has lost so much profit or capital, he now cannot afford the loss and d
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    ecides to keep the stock as a long term investment. And hopes one day it will recov
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    r and make money. (Does this ring a few bells or sound familiar?)

    The trader and i
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    nvestor do have one thing in common and that is they both profit from rising prices


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.answers.org.ua/article/116416/answers-Are-You-Trader-Or-An-Investor.html">Are You Trader Or An Investor?</a>

    BB link (for phorums):
    [url=http://www.answers.org.ua/article/116416/answers-Are-You-Trader-Or-An-Investor.html]Are You Trader Or An Investor?[/url]

    Related Articles:

    Impossible - At First Glance the Project Appeared Impossible

    I Am Shopping For - The Best Way To Sell My Products Online

    How Do I Make My Very Own Free Website With My Own Domain?

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com